Yael P Mossé MD

Neuroblastoma developmental therapeutics

1. Familial Neuroblastoma.
2. ALK as a Tractable Molecular Target in Neuroblastoma.
3. Translational Research and Innovative Therapy Development.
4. Antibody Targeting of the Anaplastic Lymphoma Kinase Oncogene.